May 26th, 2009

2009 Annual Meeting Webcast

Objectives : Return to Annual Meeting Archive Introduction This scientific program is designed to provide surgeons with an in-depth and up-to-date knowledge relative to surgery for diseases of the colon, rectum and anus with emphasis on patient care, teaching and research. The purpose of all sessions is to improve the quality of care of patients with diseases of the colon and rectum.   Target Audience The program is intended for the education of colon and rectal surgeons as well as general surgeons and others involved in the treatment of diseases affecting the colon, rectum and anus. Minimum System Requirements Any high spped internet connection. An internet browser with flash 8 or later installed. Privacy Statement The American Society of Colon&Rectal Surgeons is committed to maintaining the privacy of the personal information of visitors to its sites.  Our policies are designed to disclose the information collected and how it will be used.  This policy applies solely to the information provided while visiting this website.  The terms of the privacy policy do not govern personal information furnished through any means other than this website (such as by telephone or mail). Agreement All images contained in this presentation are copyrighted  by the American Society of Colon and Rectal Surgeons. Disclaimer The primary purpose of the ASCRS Annual Meeting and this webcast is education. Information, as well as technologies, products and/or services discussed, are intended to inform participants about the knowledge, techniques and experiences of specialists who are willing to share such information with collagues.   A diversity of professional opinions exist in the specialty and the views of the American Society of Colon and Rectal Surgeons disclaims any and all liability for information, technologies, products and/or services discussed.

American Cancer Society Presentation

Objectives : The American Cancer Society (ACS) is committed to fighting cancer through balanced programs of research, advocacy, education, and service to patients, caregivers, and survivors.  Dr. Brawley will discuss current initiatives in each of these areas and educate ASCRS members on the resources available for physicians and patients from the American Cancer Society.

______________________

24/7 - How the American Cancer Society is Working for You and Your Patients

Speaker(s) : Otis Webb Brawley, MD

Benign I

Objectives : At the conclusion of this session, participants should be able to: (13) appreciate the feasibility of laparoscopic peritoneal lavage as an alternative operative approach to generalised peritonitis due to perforated Diverticulitis; (14) appreciate that the advantages of laparoscopic surgery can be applied to the emergency management of complicated Diverticulitis; (15) understand the indications for laparoscopic resection of diverticulitis and the results which may be acheived in centres with the appropriate level of expertise; (16) a) discuss the longer term results with the bioprosthetic anal fistula plug for the management of anal fistulas and b) describe predictors of failure for the bioprosthetic anal fistula plug; (17) a) understand the failure of some fistula treatments;  b) be aware of the necessities for success of treatments and c) be up-to-date with the latest research attempts in fistula treatments;(18) a) know the success and or failure rate of a bioprosthetic plug in the management of anorectal fistulas and b) know the potential complications associated with the use of a bioprosthetic anal fistula plug; (19) a) define the incidence of chronic anal fistula or recurrent perirectal sepsis following a first time anal sepsis and b) list risk factors leading to chronic anal fistula or recurrent perirectal sepsis following a first time anal sepsis; (20) analyze the difference  in outcome of anal fistula repair by endorectal advancement flap or anal fistula plug;(21) a) assess the role of stapled transanal rectal resection in the treatment of obstructed defaecation and b) be aware of complications and limitations of this technique; (22)comprehend the safety and efficacy outcomes associated with Stapled Transanal Rectal Resection (STARR) for obstructed defaecation syndrome; (23) understand that the new procedure of STARR is safe in colorectal surgeons with an interest in pelvic floor and who have been adequately trained; and (24) understand the clinical outcomes associated with the stapled transanal rectal resection and transvaginal rectocele repair for the management of obstructive defecation syndrome.

______________________

Laparoscopic Peritoneal Lavage for Generalized Peritonitis Due to Perforated Diverticulitis - A Feasible Alternative

Speaker(s) : M. Hurley , M. Hurley D. Kavanagh , M. Hurley D. Kavanagh E. Myers , M. Hurley D. Kavanagh E. Myers G. Sullivan , M. Hurley D. Kavanagh E. Myers G. Sullivan D.C. Winter


______________________

Emergency Laparoscopic Surgery for Complicated Diverticular Disease

Speaker(s) : A. Dixon , A. Dixon G. Greenslade , A. Dixon G. Greenslade S. Phillips


______________________

Experience of 500 Consecutive Cases Justifies Laparoscopic Resection of Diverticulitis

Speaker(s) : D. Clark , D. Clark O. Jones , D. Clark O. Jones J. Lumley , D. Clark O. Jones J. Lumley A. Stevenson , D. Clark O. Jones J. Lumley A. Stevenson R. Stitz


______________________

Long Term Results with the Bioprosthetic Anal Fistula Plug

Speaker(s) : C. Ellis , C. Ellis J. Rostos


______________________

100% Pre-Clinical Success with a New Sphincter Conserving Treatment for Anal Fistula

Speaker(s) : C. Cohn , C. Cohn R. Himpson , C. Cohn R. Himpson R. Phillips , C. Cohn R. Himpson R. Phillips P. Sibbons


______________________

Treatment of Fistula-in-ano Using Porcine Small Intestinal Submucosa (Surgisis® AFP™)

Speaker(s) : H. Abcarian , H. Abcarian E. Birnbaum , H. Abcarian E. Birnbaum V. Chaudhry , H. Abcarian E. Birnbaum V. Chaudhry J. Cintron , H. Abcarian E. Birnbaum V. Chaudhry J. Cintron J. Fleshman , H. Abcarian E. Birnbaum V. Chaudhry J. Cintron J. Fleshman S. Hunt , H. Abcarian E. Birnbaum V. Chaudhry J. Cintron J. Fleshman S. Hunt M. Mutch , H. Abcarian E. Birnbaum V. Chaudhry J. Cintron J. Fleshman S. Hunt M. Mutch M. Poirier , H. Abcarian E. Birnbaum V. Chaudhry J. Cintron J. Fleshman S. Hunt M. Mutch M. Poirier S. Tenfelde


______________________

Who is at Risk for Developing Chronic Anal Fistula or Recurrent Sepsis after Initial Perirectal Abscess?

Speaker(s) : M. Abbas , M. Abbas P. Haigh , M. Abbas P. Haigh A. Hamadani , M. Abbas P. Haigh A. Hamadani A. Liu


______________________

Treatment of Transsphincteric Anal Fistulas by Endorectal Advancement Flap or Anal Fistula Plug: A Comparative Study

Speaker(s) : D. Christoforidis , D. Christoforidis S. Goldberg , D. Christoforidis S. Goldberg R. Madoff , D. Christoforidis S. Goldberg R. Madoff A. Mellgren , D. Christoforidis S. Goldberg R. Madoff A. Mellgren M. Pieh


______________________

Stapled Transanal Rectal Resection for Obstructed Defaecation Secondary to Rectocoele and Recto-anal Intussusception: A Cautionary Tale

Speaker(s) : H. Carter , H. Carter A. Dixon , H. Carter A. Dixon L. Titu


______________________

STARR for Obstructed Defecation Syndrome: 12 Month Follow-up

Speaker(s) : D. Jayne , D. Jayne O. Schwander , D. Jayne O. Schwander A. Stuto


______________________

STARR - Is it Safe?

Speaker(s) : A. Clarke , A. Clarke A. Dixon , A. Clarke A. Dixon P. Durdey , A. Clarke A. Dixon P. Durdey D. Gold , A. Clarke A. Dixon P. Durdey D. Gold M. Lamparelli , A. Clarke A. Dixon P. Durdey D. Gold M. Lamparelli K. Nugent , A. Clarke A. Dixon P. Durdey D. Gold M. Lamparelli K. Nugent C. Oppong , A. Clarke A. Dixon P. Durdey D. Gold M. Lamparelli K. Nugent C. Oppong C. Vickery


______________________

Clinical Outcomes of Stapled Transanal Rectal Resection as Compared to Transvaginal Rectocele Repair for the Management of Obstructive Defecation Syndrome

Speaker(s) : J. Aversa , J. Aversa S. DeJesus , J. Aversa S. DeJesus A. Ferrara , J. Aversa S. DeJesus A. Ferrara J. Gallagher , J. Aversa S. DeJesus A. Ferrara J. Gallagher M. Harris , J. Aversa S. DeJesus A. Ferrara J. Gallagher M. Harris L. Kosinski , J. Aversa S. DeJesus A. Ferrara J. Gallagher M. Harris L. Kosinski S. Larach , J. Aversa S. DeJesus A. Ferrara J. Gallagher M. Harris L. Kosinski S. Larach L. Norcross , J. Aversa S. DeJesus A. Ferrara J. Gallagher M. Harris L. Kosinski S. Larach L. Norcross P. Williamson

Benign II

Objectives : At the conclusion of this session, participants should be able to: (61) describe the predictors of a poor outcome after colectomy for fulminant clostridium difficile infections; (62) identify parameters associated with poor outcome in patients with C. difficile colitis; (63) a) describe a technique to repair parastomal hernias using bioprosthetics and b) discuss the safety and efficicy of a bioprosthetic for the management of parastomal hernias; (64) understand what extent reoperations after stapler hemorrhoidpexy are necessary; (65) a) appreciate the effectiveness of biofeedback in pelvic floor dysfunction type constipation and b) appreciate the need for quality research in pelvic floor dysfunction; (66) differentiate local perianal repair vs. pouch reconstruction with Ileoana pouch salvage surgery. Secondly, patients with crohn's disease suited for pouch excision; (67) understand the difference in views between pregnant women and clinicians with regards to potential complications associated with vaginal delivery and elective caesarean section; (68) appreciate the advantages of minimally invasive surgery and an anterior rectal mobilization for both external and internal rectal prolapse; (69) a) gain an understanding of the community prevalence of fecal incontinence (FI) in the Western world, which is often underestimated; b) develop an understanding of symptom severity, quality of life, risk factors and medical care seeking behavior for individuals with FI in the community and c) develop an appreciation for ethnic differences in rates of FI and the methodology required to explore such a difference; (70) a) understand the indications for Sacral nerve stimulation for fecal incontinence and b) appreciate the likely results of this technique in the medium term; (71) sacral nerve stimulation (SNS) is a valid option to treat patients with fecal incontinence (FI). Implant procedure is safe and non-invasive, and clinical effectiveness is maintained at medium-term period. However, long-term results are still unknown; (72) develop a strategy for neurostimulator programming in patients undergoing sacral nerve stimulation for fecal incontinence.

______________________

Correlates of Post-operative Mortality among Patients Undergoing an Emergency Colectomy for Fulminant Clostridium Difficile Infection

Speaker(s) : M. Boutros , M. Boutros S. Dial , M. Boutros S. Dial A. Labbe , M. Boutros S. Dial A. Labbe E. Marcotte , M. Boutros S. Dial A. Labbe E. Marcotte C. Patino , M. Boutros S. Dial A. Labbe E. Marcotte C. Patino J. Pepin , M. Boutros S. Dial A. Labbe E. Marcotte C. Patino J. Pepin C. Vasilevsky , M. Boutros S. Dial A. Labbe E. Marcotte C. Patino J. Pepin C. Vasilevsky T. Vo


______________________

C. Difficile Colitis - Predictors of Fatal Outcome

Speaker(s) : H. Dudukgian , H. Dudukgian D. Etzioni , H. Dudukgian D. Etzioni C. Gonzalez-Ruiz , H. Dudukgian D. Etzioni C. Gonzalez-Ruiz A. Kaiser , H. Dudukgian D. Etzioni C. Gonzalez-Ruiz A. Kaiser E. Sie


______________________

Results with the Use of a Bioprosthetics for the Management of Parastomal for the Management of Parastomal

Speaker(s) : C. Ellis , C. Ellis M. Knight


______________________

Reoperations after Stapled Hemorrhoidopexy

Speaker(s) : J. Bock , J. Bock A. Eberstein , J. Bock A. Eberstein J. Jongen , J. Bock A. Eberstein J. Jongen V. Kahlke , J. Bock A. Eberstein J. Jongen V. Kahlke H. Peleikis


______________________

Effectiveness of Biofeedback in Adults with Pelvic Floor Dysfunction

Speaker(s) : C. Koh , C. Koh M. Solomon , C. Koh M. Solomon C. Young , C. Koh M. Solomon C. Young J. Young


______________________

Reoperative IPAA Surgery - Factors Predictive of Success

Speaker(s) : A. Belizon , A. Belizon J. Nogueras , A. Belizon J. Nogueras D. Sands , A. Belizon J. Nogueras D. Sands S. Shawki , A. Belizon J. Nogueras D. Sands S. Shawki E. Weiss , A. Belizon J. Nogueras D. Sands S. Shawki E. Weiss S. Wexner


______________________

Vaginal Delivery Compared with Elective Caesarean Section: The Views of Pregnant Women and Clinicians

Speaker(s) : C. Benness , C. Benness J. Ludlow , C. Benness J. Ludlow H. Phipps , C. Benness J. Ludlow H. Phipps M. Solomon , C. Benness J. Ludlow H. Phipps M. Solomon C. Turner , C. Benness J. Ludlow H. Phipps M. Solomon C. Turner J. Young


______________________

Laparoscopic Anterior Rectopexy for External and Internal Rectal Prolapse

Speaker(s) : R. Collinson , R. Collinson C. Cunningham , R. Collinson C. Cunningham I. Lindsey


______________________

The Community Prevalence of Fecal Incontinence: A New Zealand Cross-Sectional Study

Speaker(s) : I. Bissett , I. Bissett A. Macmillan , I. Bissett A. Macmillan A. Merrie , I. Bissett A. Macmillan A. Merrie P. Reid , I. Bissett A. Macmillan A. Merrie P. Reid A. Sharma


______________________

Sacral Nerve Neuromodulation is Effective Treatment for Fecal Incontinence in the Presence of a Sphincter Defect or Previous Sphincter Repair

Speaker(s) : R. Brouwer , R. Brouwer G. Duthie


______________________

Sacral Nerve Stimulation in Fecal Incontinence: Results 5 Years after Implant

Speaker(s) : D. Altomare , D. Altomare E, Ganio , D. Altomare E, Ganio P. Lolli , D. Altomare E, Ganio P. Lolli C. Ratto , D. Altomare E, Ganio P. Lolli C. Ratto R. Villani


______________________

Improving the Efficacy of Sacral Nerve Stimulation for Fecal Incontinence by Alteration of Stimulation Parameters

Speaker(s) : T. Dudding , T. Dudding A. Gibbs , T. Dudding A. Gibbs M. Kamm , T. Dudding A. Gibbs M. Kamm C. Vaizey

Supported by an educational grant from Wyeth Pharmaceuticals

Best Evidence and Practical Advice in Managing Post Operative Ileus- 2008 and Beyond

Supported by an educational grant from Wyeth Pharmaceuticals

Objectives : At the conclusion of this session, participants should be able to: a) recognize the impact of POI on patient health; b) implement early monitoring for POI; c) integrate best available evidence in treating POI in their patients; d) effectively manage pain while minimizing the potential for POI; and e) shorten length of stay for patients with POI and reduce health care costs burden on patients.

______________________

Post Operative Ileus—An Overview

Speaker(s) : Steven R. Hunt, MD

Steven R. Hunt, MD
Evaluation
______________________

Evaluating the Problem—Case-based Approach

Speaker(s) : Rocco Ricciardi, MD


______________________

Latest Developments and Best Available Evidence in the Treatment and Management of POI

Speaker(s) : Najjia N. Mahmoud, MD

Core Subject Update

Objectives : At the conclusion of this session, participants should be able to: a) identify etiologic factors that contribute to rectal prolapse, intussussception and solitary rectal ulcer syndrome; understand abdominal and perineal approaches to the surgical treatment of these conditions; b) discuss the epidemiology and theories of pathophysiology of ulcerative colitis; clinical features and diagnosis of ulcerative colitis; the medical management of ulcerative colitis; and the options for surgical treatment of ulcerative colitis, including the use of laparoscopy; c) understand the evaluation and treatment of retrorectal tumors and the evaluation and treatment of anal tumors; d) identify the epidemiological and underlying causative or contributing factors to the development of volvulus; describe the diagnostic evaluation, endoscopic and surgical approaches to management, and outcomes for both cecal and sigmoid volvulus; describe the evaluation and management associated with colon and rectal trauma and describe the differences in surgical outcomes associated with primary repair, resection and diversion for colon and rectal trauma; e) describe the clinical features of a patient with colorectal cancer which are suggestive of an inherited cancer syndrome and discuss the clinical evaluation and management of a patient with a suspected inherited cancer syndrome.

______________________

Hemorrhoids, Fissure
Presented by: Philip H. Gordon, MD

Speaker(s) : Nancy Morin, MD

Evaluation Form
______________________

Prolapse Intussusception SRUS

Speaker(s) : Madhulika Varma, MD


______________________

Ulcerative Colitis

Speaker(s) : David Maron, MD


______________________

Trauma, Volvulus

Speaker(s) : Scott R. Steele, MD


______________________

Hereditary Colon Cancer / Genetic Testing

Speaker(s) : C. Neal Ellis, MD


______________________

Benign and Malignant Anal Tumors Retrorectal Tumors

Speaker(s) : Kelli Bullard Dunn, MD

Ernestine Hambrick Lectureship

Objectives :

______________________

Disparities in Colorectal Cancer Care: A Quality of Care Conundrum

Speaker(s) : Selwyn O. Rogers, Jr., MD, MPH

Harry E. Bacon Lectureship

Objectives :

______________________

Technology and Technique – The Tortuous Path to Competence

Speaker(s) : Russell Stitz, MD

Supported by an educational grant from Myriad Genetic Laboratories

Identification, Testing and Treatment of Patients with HNPCC (PODCASTS)

Supported by an educational grant from Myriad Genetic Laboratories

Objectives :

______________________

Molecular Basis for HNPCC

Speaker(s) : Nigel Hall, DM, (Gen)

Download the latest version of the recommended software  iTunes or QuickTime.


______________________

How to Identify and Diagnose Patients with HNPCC

Speaker(s) : James Church, MD

Download the latest version of the recommended software  iTunes or QuickTime.


______________________

Treatment Options for HNPCC Patients

Speaker(s) : Zane Cohen, MD

Download the latest version of the recommended software  iTunes or QuickTime.


______________________

Surveillance Recommendations for Patients with HNPCC
PODCAST

Speaker(s) : Laura Renkonen-Sinisalo, MD, PhD

Download the latest version of the recommended software  iTunes or QuickTime.

Improving the Quality of Care through the Use of Population Data. A Comparison of Four Countries

Objectives : At the conclusion of this session, participants should be able to: understand how population databases are created, maintained, and utilized throughout the world to monitor treatment and quality of surgical care.

______________________

How We Do it in Norway

Speaker(s) : Arne Wibe, MD, PhD


______________________

How We Do it in the UK

Speaker(s) : Jason Smith, MB BS MD DMI (Gen Surg)


______________________

How We Do it in Australia

Speaker(s) : Michael J. Solomon, MSc, MBBS, BAO


______________________

How We Do it in Canada

Speaker(s) : Andrew Smith, MD, MSc

Inflammatory Bowel Disease I

Objectives : At the conclusion of this session, participants should be able to: (37) comprehend the affect of anatomotic type on outcomes for patients developing anastomotic separation after ileoanal pouch anastomoses; (38) understand potential complications and long terms outcomes when using anti-adhesive agents during restorative proctocolectomy; (39) a) recognize factors that result in use of protective diverting ileostomies for IPAA and b) identify factors associated with anastomotic leaks in IPAA; (40) comprehend repeat IPAA; (41) understand the impact of anastomotic leak on functional and quality of life outcomes following restorative proctocolectomy; (42) state whether minimally invasive 3-stage ileal pouch-anal anastomosis can be safely performed in patients with severe or fulminant ulcerative colitis; (43) assess the safety of laparoscopic total colectomy employed in acute severe colitis; (44) a) analyze the impact of laparoscopic vs open total abdominal colectomy for severe colitis and b) analyze the impact of the surgical approach for severe colitis on the subsequent completion restorative proctectomy; (45) understand the benefit of laparoscopic surgery for ulcerative colitis patients; (46) a) analyze the differences of laparoscopic restorative proctocolectomy and total abdominal (47) assess the postoperative results of laparoscopic ileocecal resection in complicated (i.e. fistula, abcess or recurrence) vs uncomplicated Crohn's disease; and (48) a) determine the system related factors that play a role in the surgical approach to ileocolonic Crohn's disease and b) compare the short-term outcomes associated with laparoscopic versus open surgical approach for Crohn's disease.

______________________

Outcomes for Patients Developing Anastomotic Leak after Ileoanal Pouch Anastomosis: Does it Matter Whether They had a Handsewn or a Stapled Anastomosis?

Speaker(s) : V. Fazio , V. Fazio P. Kiran , V. Fazio P. Kiran I. Lavery , V. Fazio P. Kiran I. Lavery L. Lian , V. Fazio P. Kiran I. Lavery L. Lian F. Remzi


______________________

The Effect of Seprafilm on Septic Complications and Bowel Obstruction following Primary Restorative Proctocolectomy

Speaker(s) : J. Cornish , J. Cornish V. Fazio , J. Cornish V. Fazio R. Kiran , J. Cornish V. Fazio R. Kiran H. Kirat , J. Cornish V. Fazio R. Kiran H. Kirat F. Remzi , J. Cornish V. Fazio R. Kiran H. Kirat F. Remzi E. Tan , J. Cornish V. Fazio R. Kiran H. Kirat F. Remzi E. Tan P. Tekkis


______________________

Gender is a Risk Factor for Anastomotic Leak in Ileal Pouches

Speaker(s) : M. Cripps , M. Cripps J. Garcia-Aguilar , M. Cripps J. Garcia-Aguilar M. Varma


______________________

Repeat Pouch Surgery Safely Salvages Failed Ileal Pouch Anal Anastomosis

Speaker(s) : V. Fazio , V. Fazio R. Kiran , V. Fazio R. Kiran H. Kirat , V. Fazio R. Kiran H. Kirat I. Lavery , V. Fazio R. Kiran H. Kirat I. Lavery F. Remzi , V. Fazio R. Kiran H. Kirat I. Lavery F. Remzi J. Wu


______________________

Septic Complications after Restorative Proctocolectomy Do Not Impair Functional Outcome: Long Term Follow-up from a Specialty Center

Speaker(s) : J. Bauer , J. Bauer D. Bub , J. Bauer D. Bub D. Chessin , J. Bauer D. Bub D. Chessin S. Gorfine , J. Bauer D. Bub D. Chessin S. Gorfine A. Royston , J. Bauer D. Bub D. Chessin S. Gorfine A. Royston H. Salinas , J. Bauer D. Bub D. Chessin S. Gorfine A. Royston H. Salinas D. Wong


______________________

Minimally Invasive Subtotal Colectomy and Ileal Pouch-anal Anastomosis for Fulminant Ulcerative Colitis: Feasibility and Short-term Outcomes

Speaker(s) : R. Cima , R. Cima E. Dozois , R. Cima E. Dozois S. Holubar , R. Cima E. Dozois S. Holubar D. Larson , R. Cima E. Dozois S. Holubar D. Larson J. Pattanaarun , R. Cima E. Dozois S. Holubar D. Larson J. Pattanaarun J. Pemberton


______________________

Laparoscopic Total Colectomy and Ileostomy for Acute Severe Colitis

Speaker(s) : D. Clark


______________________

Laparoscopic vs. Open Total Abdominal Colectomy for Severe Colitis: Impact on Recovery and Subsequent Completion Restorative Proctectomy

Speaker(s) : E. Birnbaum , E. Birnbaum T. Chung , E. Birnbaum T. Chung D. Dietz , E. Birnbaum T. Chung D. Dietz J. Fleshman , E. Birnbaum T. Chung D. Dietz J. Fleshman S. Hunt , E. Birnbaum T. Chung D. Dietz J. Fleshman S. Hunt J. Lowney , E. Birnbaum T. Chung D. Dietz J. Fleshman S. Hunt J. Lowney M. Mutch , E. Birnbaum T. Chung D. Dietz J. Fleshman S. Hunt J. Lowney M. Mutch T. Read , E. Birnbaum T. Chung D. Dietz J. Fleshman S. Hunt J. Lowney M. Mutch T. Read Y. Yan


______________________

Laparoscopic Restorative Proctocolectomy with Ileal Pouch Anal Anastomosis. A Comparative Prospective Study on Long-term Functional Results

Speaker(s) : A. Fichera , A. Fichera R. Hurst , A. Fichera R. Hurst F. Michelassi , A. Fichera R. Hurst F. Michelassi M. Rubin , A. Fichera R. Hurst F. Michelassi M. Rubin M. Silvestri


______________________

Safety and Feasibility of Laparoscopic Surgery as an Initial Treatment for Ulcerative Colitis

Speaker(s) : S. Lee , S. Lee Jeffrey W. Milsom, MD , S. Lee Jeffrey W. Milsom, MD T. Sonoda , S. Lee Jeffrey W. Milsom, MD T. Sonoda K. Trencheva , S. Lee Jeffrey W. Milsom, MD T. Sonoda K. Trencheva S. Yun


______________________

Impact of Complicated Crohn's Disease on the Outcome of Laparoscopic Ileocecal Resection: a Comparative Clinical Study in 124 Patients

Speaker(s) : A. Alves , A. Alves Y. Bouhnik , A. Alves Y. Bouhnik F. Bretagnol , A. Alves Y. Bouhnik F. Bretagnol P. Goyer , A. Alves Y. Bouhnik F. Bretagnol P. Goyer Y. Panis


______________________

National Trends and Outcomes for the Surgical Therapy of Ileocolonic Crohn's Disease: A Population-based Analysis of Laparoscopic vs. Open Approaches

Speaker(s) : L. Brounts , L. Brounts R. Lehmann , L. Brounts R. Lehmann K. Lesperance , L. Brounts R. Lehmann K. Lesperance M. Martin , L. Brounts R. Lehmann K. Lesperance M. Martin S. Steele

Inflammatory Bowel Disease II

Objectives : At the conclusion of this session, participants should be able to: (85) have a better understanding of the frequency and type of perianal surgical disease in patients with Crohns disease; (86) discuss indications for use of infliximab, indications for surgery in patients with inflamatory bowel disease, differences in surgical presentation of patients treated with or without infliximab and their choice of surgical procedures; (87) understand the long term outcome of inflixamab in the treatment of complex perianal Crohn's fistulas; (88) describe the patient and disease charateristics that are associated with early resection in a population cohort; (89) discuss the outcome of ileal pouch-anal anastomosis in patients with indeterminate colitis; (90) a) recognize S. typhimurium as a novel cytokine delivery vehicle and b) understand the rationale for utilization of this construct for treatment of experimental inflammatory bowel disease; (91) understand that recurrence occurs in half of the patients with crohn's disease after laparoscopic ileocolectomy. Use of post operative immunomodulating prophylaxis may be of limited benefit in delaying recurrence; (92) a) discuss the importance of inflammation in regards to colectomy for chronic ulcerative colitis and b) understand the risk factors for colectomy in patients with chronic ulcerative colitis; (93) understand the incidence and implications of pre-pouch ileitis following IPAA Understand how to manage patients with pre-pouch ileitis; (94) understand that abdominal CT scan does not impact the rate of same admission colectomy in patients with toxic colitis; (95) appreciate the consensus opinion of UK Coloproctologists and Gastroenterologists in the management of terminal ileitis in the acute and elective setting trainees will be able to use this information in making their own informed decision in the scenarios presented; and (96) understand the advantages in clinical outcomes, quality of life and cost effectiveness of percutaneous drainage followed by elective surgery vs. primary surgery for Crohn's disease presenting with abdomino-pelvic abscess.

______________________

Surgery for Perianal Disease in a Population-based Crohn's Disease Cohort

Speaker(s) : M. Barclay , M. Barclay F. Frizelle , M. Barclay F. Frizelle R. Gearry


______________________

Preoperative Treatment with Infliximab does not Increase Rate of Emergent or Multi-step Abdominal Surgery

Speaker(s) : L. Bordeianou , L. Bordeianou R. Hodin , L. Bordeianou R. Hodin J. Korzenik , L. Bordeianou R. Hodin J. Korzenik H. Kunitake , L. Bordeianou R. Hodin J. Korzenik H. Kunitake B. Sands , L. Bordeianou R. Hodin J. Korzenik H. Kunitake B. Sands P. Shellito


______________________

Long Term Outcome of Infliximab in the Treatment of Complex Perianal Crohn

Speaker(s) : W. Buie , W. Buie A. MacLean , W. Buie A. MacLean R. Panaccione , W. Buie A. MacLean R. Panaccione D. Topstad


______________________

Characteristics of Resectional Surgery in a Population-based Inflammatory Bowel Disease Cohort

Speaker(s) : M. Barclay , M. Barclay F. Frizelle , M. Barclay F. Frizelle R. Gearry


______________________

A Prospective Evaluation of the Long-Term Outcome of Ileal Pouch-anal Anastomosis in Patients with Indeterminate Colitis

Speaker(s) : P. Fleshner , P. Fleshner Z. Murrell


______________________

IL-10 Producing Attenuated Salmonella Typhimurium is Beneficial for Treatment of DSS Induced Murine Inflammatory Bowel Disease

Speaker(s) : C. Heise , C. Heise J. Lan


______________________

Risk Factors for Recurrence and the Impact of Post-operative Prophylaxis in Ileal Colonic Crohn's Disease

Speaker(s) : R. Cima , R. Cima E. Dozois , R. Cima E. Dozois W. Faubion , R. Cima E. Dozois W. Faubion R. Gullerud , R. Cima E. Dozois W. Faubion R. Gullerud D. Larson , R. Cima E. Dozois W. Faubion R. Gullerud D. Larson E. Loftus , R. Cima E. Dozois W. Faubion R. Gullerud D. Larson E. Loftus K. Malireddy , R. Cima E. Dozois W. Faubion R. Gullerud D. Larson E. Loftus K. Malireddy D. Pardi , R. Cima E. Dozois W. Faubion R. Gullerud D. Larson E. Loftus K. Malireddy D. Pardi R. Qin , R. Cima E. Dozois W. Faubion R. Gullerud D. Larson E. Loftus K. Malireddy D. Pardi R. Qin W. Sandborn , R. Cima E. Dozois W. Faubion R. Gullerud D. Larson E. Loftus K. Malireddy D. Pardi R. Qin W. Sandborn B. Wolff


______________________

Severity of Inflammation as a Predictor of Colectomy in Patients with Chronic Ulcerative Colitis

Speaker(s) : D. Chessin , D. Chessin N. Harpaz , D. Chessin N. Harpaz M. Hefti , D. Chessin N. Harpaz M. Hefti R, Steinhagen , D. Chessin N. Harpaz M. Hefti R, Steinhagen T. Ullman


______________________

CT Scan for Severe Acute

Speaker(s) : M. Baker , M. Baker V. Fazio , M. Baker V. Fazio I. Mor , M. Baker V. Fazio I. Mor A. Moreira , M. Baker V. Fazio I. Mor A. Moreira J. Vogel , M. Baker V. Fazio I. Mor A. Moreira J. Vogel R. Zhang


______________________

Terminal Ileal Crohn's Disease - Aggressive Physician and Conservative Surgeon?

Speaker(s) : S. Brown , S. Brown H. Narula , S. Brown H. Narula U. Shariff , S. Brown H. Narula U. Shariff W. Speake


______________________

Outcomes of Crohn's Disease Presenting with Abdomino-Pelvic Abscess: A Decision Analysis

Speaker(s) : V. Fazio , V. Fazio A. Moreira , V. Fazio A. Moreira L. Stocchi , V. Fazio A. Moreira L. Stocchi E. Tan , V. Fazio A. Moreira L. Stocchi E. Tan P. Tekkis

International View on Rectal Cancer

Objectives : At the conclusion of this session, participants should be able to understand the workup and treatment of rectal cancer and differences in available treatment strategies.

______________________

Preoperative Staging: North American Approach

Speaker(s) : Juan Nogueras, MD


______________________

Preoperative Staging: European Approach

Speaker(s) : Paul Finan, MD


______________________

Optimal Treatment of Stages II and III Rectal Cancer: North American Approach

Speaker(s) : David Rothenberger, MD


______________________

Optimal Treatment of Stages II and III Rectal Cancer: European Approach

Speaker(s) : Brendan Moran, MD

John Goligher Lectureship

Objectives :

______________________

Radical Pelvic Exenteration for Advanced and Recurrent Rectal Cancer: Techniques and Outcomes

Speaker(s) : Michael J. Solomon, MSc, MBBS, BAO

Laparoscopic Techniques: Nuts and Bolts and Beyond

Objectives : At the conclusion of this program, participants should be able to understand the different Laparoscopic surgical approaches that exist for the common colorectal resections; thus, improving surgical skills.

______________________

Middle Colic Dissection and Division: Straight Laparoscopic, Inferior Approach

Speaker(s) : John Marks, MD


______________________

Middle Colic Dissection and Division: Straight Laparoscopic, Superior Approach

Speaker(s) : Conor Delaney, MD, MCh, PhD


______________________

Middle Colic Dissection and Division: Hand-assisted Approach

Speaker(s) : David Rivadeneira, MD


______________________

Splenic Flexure Takedown for Transverse Colectomy: Starting at IMV, Medial to Lateral

Speaker(s) : Daniel Feingold, MD


______________________

Pelvic Exposure: Large Uterus: Retraction via Transabdominal Fixation Sutures

Speaker(s) : Alex Ky, MD


______________________

Laparoscopic Uteropexy

Speaker(s) : Nadav Dujovny, MD


______________________

Pelvic Exposure: Large Uterus: Transvaginal Intrauterine Manipulators

Speaker(s) : Toyooki Sonoda, MD


______________________

Retraction and Exposure of Pelvic Dissection Planes Laparoscopically (2 person technique)

Speaker(s) : Richard Whelan, MD


______________________

LAR: Deep Pelvic Rectal Mobilization: Straight Laparoscopic Methods

Speaker(s) : John R. T. Monson, MD


______________________

LAR: Making Window Between Rectum and Mesorectum Intracorporeally During Anterior Resection in Preparation for Distal Bowel and Mesenteric Division: Hand and Straight Lap Methods

Speaker(s) : Morris Franklin, MD


______________________

LAR: Intracorporeal Division of Distal Rectum

Speaker(s) : John Marks, MD


______________________

LAR: Different Staplers for Intracorporeal Division of the Rectum Distally

Speaker(s) : Sang Lee, MD


______________________

Hand-assisted Division of Mesorectum and Rectum via Open Methods via the Hand Port Incision

Speaker(s) : Sang Lee, MD


______________________

Adhesions Talk

Speaker(s) : Peter Marcello, MD


______________________

Surgery in the Obese: Right Colectomy, Medial to Lateral, Straight Lap Approach

Speaker(s) : Anthony Senagore, MD, MS, MBA


______________________

Surgery in the Obese: Right Colectomy, Inferior and Lateral to Medial Approaches

Speaker(s) : Jonathan Efron, MD


______________________

Surgery in the Obese: Omental Peel

Speaker(s) : Matthew Mutch, MD


______________________

Intracorporeal Ileocolic Anastomosis

Speaker(s) : Mark Whiteford, MD


______________________

Surgery in the Obese: Sigmoid / Descending Colon Mobilization, Straight Laparoscopic

Speaker(s) : Michael Parker, MD


______________________

Surgery in the Obese: Sigmoid / Descending Colon Mobilization, Hand-assisted Approach

Speaker(s) : Jeffrey Cohen, MD


______________________

Sigmoid Colectomy for Diverticulitis: Midmesenteric Division, Sparing of Main Sigmoidal Vessels and Nerves

Speaker(s) : Sharon Stein, MD

Louis A. Buie, MD Lectureship

Objectives :

______________________

Do We Know What We Know?
Notes on the Epistemology of Surgery

Speaker(s) : Robert D. Madoff, MD

Modern Treatment of Diverticulitis

Objectives : At the conclusion of this session, participants should be able to: understand the workup and treatment strategies for patients with diverticulitis.

______________________

Optimal Treatment of Diverticulitis in the Young Patient

Speaker(s) : Steven D. Wexner, MD


______________________

Nonoperative Approaches to Diverticulitis

Speaker(s) : W. Donald Buie, MD


______________________

Treatment of Complicated Diverticulitis Including Abscess, Stricture, or Fistula

Speaker(s) : P. Ronan O'Connell, MD


______________________

Early Versus Late Operation for Diverticulitis

Speaker(s) : Alan Meagher, MD

Neoplasia I

Objectives : At the conclusion of this session, participants should be able to: (1) a)analyze the outcomes obtained in a centre of large volume laparoscopic colorectal surgery and b)select suitable cases for laparoscopic proctectomy for rectal cancer; (2) understand the differences in long-term morbidity and oncological outcomes between laparoscopic and open anterior resection for upper rectal cancer; (3) a) recognize that robotic-assisted low anteior resection was performed safely and effectively, using the da Vinci® Surgical System and b) recognize that use of the da Vinci® Surgical System resulted in acceptable perioperative outcomes comparing with laparoscopic low anteior resection; (4) understand that laparoscopic surgery for rectal cancer has favorable outcome with low recurrence rate, negative margins and overall survival rate comparable to open surgery; (5) a0 appreciate the high rate of margin involvement for low rectal tumours treated by abdomino-perineal excision and b) understand that low rectal tumours treated with abdomino-perineal excision tend to be more locally advanced, despite an increased use of neoadjuvant therapies;(6) a) review short-term operative outcomes and long-term oncologic outcomes of extended lymph node dissection for the treatment of rectal cancer and b) understand the prognosis of the patients according to the location of metastatic lymph nodes and develop a plan to treat those patients with metastatic lymph nodes in lateral pelvic wall and/or paraaortic area; (7) understand the characteristics of lymph node metastasis in lower rectal cancer; (8) understand the functional outcomes for patients with pre operative radiation for rectal cancer after restorative procedures; (9) understand the risk of disease recurrence associated with transanal excision or radical resection of early rectal cancer; (10) appreciate the potential for the development of aspirin and other NSAIDs as chemopreventive agents; (11) council patients regarding risk of recurrence following transanal endoscopic microsurgery; and (12) critically analyze the decision for observation versus surgery in patients with locally advanced rectal cancer and assess the relative merits of each option.

______________________

Long Term Results after 16 years Experience with Laparoscopic Restorative Proctectomy

Speaker(s) : J. Ellis-Clark, MD , J. Ellis-Clark, MD John Lumley, MD , J. Ellis-Clark, MD John Lumley, MD A. Stevenson , J. Ellis-Clark, MD John Lumley, MD A. Stevenson Russell Stitz, MD


______________________

Long-term Morbidity and Oncological Outcomes of Laparoscopic Anterior Resection for Upper Rectal Cancer: 10-year Results of a Prospective Randomized Trial

Speaker(s) : S. Hon , S. Hon J. Lee , S. Hon J. Lee K. Leung , S. Hon J. Lee K. Leung W. Leung , S. Hon J. Lee K. Leung W. Leung J. Li , S. Hon J. Lee K. Leung W. Leung J. Li S. Ng , S. Hon J. Lee K. Leung W. Leung J. Li S. Ng D. Ng , S. Hon J. Lee K. Leung W. Leung J. Li S. Ng D. Ng R. Yiu


______________________

Robotic-assisted Low Anterior Resection of Rectal Cancer: Short-term Outcome of Prospective Randomized Trial

Speaker(s) : S. Baik , S. Baik H. Chi , S. Baik H. Chi C. Cho , S. Baik H. Chi C. Cho H. Hur , S. Baik H. Chi C. Cho H. Hur N. Kim , S. Baik H. Chi C. Cho H. Hur N. Kim A. Lee , S. Baik H. Chi C. Cho H. Hur N. Kim A. Lee W. Lee , S. Baik H. Chi C. Cho H. Hur N. Kim A. Lee W. Lee S. Sohn


______________________

Long Term Outcomes of Patients Undergoing Laparoscopic Surgery for Rectal Cancer

Speaker(s) : Sang Lee, MD , Sang Lee, MD Jeffrey W. Milsom, MD , Sang Lee, MD Jeffrey W. Milsom, MD O. Oliveira , Sang Lee, MD Jeffrey W. Milsom, MD O. Oliveira S. Pandey , Sang Lee, MD Jeffrey W. Milsom, MD O. Oliveira S. Pandey Toyooki Sonoda, MD , Sang Lee, MD Jeffrey W. Milsom, MD O. Oliveira S. Pandey Toyooki Sonoda, MD K. Trencheva


______________________

Overall and Disease Free Survival for Stage III Colon Cancer Patients is Independent of the Total Number of Lymph Nodes Retrieved

Speaker(s) : R. Cima , R. Cima N. Diehl , R. Cima N. Diehl E. Dozois , R. Cima N. Diehl E. Dozois G. Kennedy , R. Cima N. Diehl E. Dozois G. Kennedy David W. Larson, MD , R. Cima N. Diehl E. Dozois G. Kennedy David W. Larson, MD R. Qin , R. Cima N. Diehl E. Dozois G. Kennedy David W. Larson, MD R. Qin V. Tsikitis , R. Cima N. Diehl E. Dozois G. Kennedy David W. Larson, MD R. Qin V. Tsikitis Bruce G. Wolff, MD


______________________

Impact of Extended Lymph Node Dissection for Rectal Cancer: Its Safety and Long Term Oncologic Outcomes

Speaker(s) : S. Baik , S. Baik C. Cho , S. Baik C. Cho H. Hur , S. Baik C. Cho H. Hur N. Kim , S. Baik C. Cho H. Hur N. Kim J. Kim , S. Baik C. Cho H. Hur N. Kim J. Kim K. Lee , S. Baik C. Cho H. Hur N. Kim J. Kim K. Lee B. Min , S. Baik C. Cho H. Hur N. Kim J. Kim K. Lee B. Min S. Sohn


______________________

Impact of Pelvic Sidewall Dissection in Lower Rectal Cancer

Speaker(s) : J. Hida , J. Hida S. Kameoka , J. Hida S. Kameoka T. Kato , J. Hida S. Kameoka T. Kato H. Kobayashi , J. Hida S. Kameoka T. Kato H. Kobayashi H. Mochizuki , J. Hida S. Kameoka T. Kato H. Kobayashi H. Mochizuki T. Mori , J. Hida S. Kameoka T. Kato H. Kobayashi H. Mochizuki T. Mori T. Morita , J. Hida S. Kameoka T. Kato H. Kobayashi H. Mochizuki T. Mori T. Morita M. Ono , J. Hida S. Kameoka T. Kato H. Kobayashi H. Mochizuki T. Mori T. Morita M. Ono Y. Saito , J. Hida S. Kameoka T. Kato H. Kobayashi H. Mochizuki T. Mori T. Morita M. Ono Y. Saito K. Shirouzu , J. Hida S. Kameoka T. Kato H. Kobayashi H. Mochizuki T. Mori T. Morita M. Ono Y. Saito K. Shirouzu K. Sugihara , J. Hida S. Kameoka T. Kato H. Kobayashi H. Mochizuki T. Mori T. Morita M. Ono Y. Saito K. Shirouzu K. Sugihara M. Ueno , J. Hida S. Kameoka T. Kato H. Kobayashi H. Mochizuki T. Mori T. Morita M. Ono Y. Saito K. Shirouzu K. Sugihara M. Ueno M. Watanabe , J. Hida S. Kameoka T. Kato H. Kobayashi H. Mochizuki T. Mori T. Morita M. Ono Y. Saito K. Shirouzu K. Sugihara M. Ueno M. Watanabe M. Yasuno


______________________

Lymph Node Harvest after Proctectomy for Invasive Rectal Adenocarcinoma following Neoadjuvant Therapy: Does the Same Standard Apply?

Speaker(s) : M. Berho , M. Berho M. Cruz Correa , M. Berho M. Cruz Correa Juan Nogueras, MD , M. Berho M. Cruz Correa Juan Nogueras, MD F. Potenti , M. Berho M. Cruz Correa Juan Nogueras, MD F. Potenti B. Safar , M. Berho M. Cruz Correa Juan Nogueras, MD F. Potenti B. Safar D. Sands , M. Berho M. Cruz Correa Juan Nogueras, MD F. Potenti B. Safar D. Sands H. Wang , M. Berho M. Cruz Correa Juan Nogueras, MD F. Potenti B. Safar D. Sands H. Wang E. Weiss , M. Berho M. Cruz Correa Juan Nogueras, MD F. Potenti B. Safar D. Sands H. Wang E. Weiss Steven D. Wexner, MD , M. Berho M. Cruz Correa Juan Nogueras, MD F. Potenti B. Safar D. Sands H. Wang E. Weiss Steven D. Wexner, MD R. Zhao


______________________

Bowel Function is Worse after Restorative Procedure with Preoperative Long Course Radiation

Speaker(s) : I. Lavery , I. Lavery S. Shedda


______________________

Long Term Survival after Surgery for T1 Rectal Cancer

Speaker(s) : J. Guillem , J. Guillem G. Nash , J. Guillem G. Nash P. Paty , J. Guillem G. Nash P. Paty J. Shia , J. Guillem G. Nash P. Paty J. Shia L. Temple , J. Guillem G. Nash P. Paty J. Shia L. Temple M. Weiser , J. Guillem G. Nash P. Paty J. Shia L. Temple M. Weiser W. Wong


______________________

UK Audit of Transanal Endoscopic Microsurgery for Rectal Cancer

Speaker(s) : S. Bach , S. Bach L. Lane , S. Bach L. Lane A. Merrie , S. Bach L. Lane A. Merrie N. Mortensen , S. Bach L. Lane A. Merrie N. Mortensen B. Warren


______________________

Observation or Surgery in Patients with Rectal Cancer: What is the Preferred Treatment for Clinical Complete Responders to Neoadjuvant Therapy?

Speaker(s) : E. Elkin , E. Elkin K. Goodman , E. Elkin K. Goodman J. Guillem , E. Elkin K. Goodman J. Guillem H. Neuman , E. Elkin K. Goodman J. Guillem H. Neuman P. Paty , E. Elkin K. Goodman J. Guillem H. Neuman P. Paty L. Temple , E. Elkin K. Goodman J. Guillem H. Neuman P. Paty L. Temple M. Weiser , E. Elkin K. Goodman J. Guillem H. Neuman P. Paty L. Temple M. Weiser W. Wong

Neoplasia II

Objectives : At the conclusion of this session, participants should be able to: (25) understand the incidence and risk factors of anal dysplasia in transplant recipients; (26) a) understand the usefullness of anal Hybrid Capture II testing for oncogenic HPV in men who have sex with men and b) understand the predictors of development of anal high-grade dysplasia in men who have sex with men; (27) develop a plan of screening anal dysplasia in high risk population. Understand the hability of anal Pap smear and high resolution anoscopy guided biopsy for detection of anal dysplasia in HIV-infected patients; (28) identify the relative contribution of HIV status to diagnosis and outcomes of anal SCC; (29) recognize the differential expression of selected genes in sessile serrated polyps; (30) a) discuss alterations in gene expression comparing CRCs with LVI compared to those without it and b) discuss the cellular pathways these genes contribute to; (31) a) analyse the genetic profile of sporadic colorectal cancers using SNP and methylation arrays and b) understand the molecular basis for the poor prognosis of microsatellite and chromosome stable colorectal cancers; (32) a) recognize that colon and rectal cancers arise via different mechanisms and b) understand the clinical implications of molecular differences between colon and rectal cancer development; (33) conclude that the total number of lymph nodes retrieved on a surgical specimen, from patients with stage III colon cancer, has no significant correlation with the patients' oncologic outcomes (i.e overall, cause specific and disease free survival); and (34) a) understand the neoadjuvant therapy significantly reduces the lymph node harvest; b) understand the patients with good primary tumor response have less lynph nodes and c) interpret the lymph node harvest based on the primary tumor response; (35) rationalize the use of whole body FDG PETCT in the clinical management of squamous cell carcinoma of the anus; (36) develop a surveillance strategy for patients with anal canal cancer.

______________________

Anal Dysplasia in Renal Allograft Recipients

Speaker(s) : K. Anderson , K. Anderson L. Downs , K. Anderson L. Downs J. Hansberger , K. Anderson L. Downs J. Hansberger R. Madoff , K. Anderson L. Downs J. Hansberger R. Madoff J. Ogilvie , K. Anderson L. Downs J. Hansberger R. Madoff J. Ogilvie I. Park


______________________

HPV Typing by Hybrid Capture II and Other Predictors of Anal High-grade Dysplasia in Men Who have Sex with Men

Speaker(s) : C. Enyinna , C. Enyinna S. Goldstone


______________________

Screening Anal Dysplasia in HIV-Infected Patients: Is There an Agreement between Anal Pap Smear and High Resolution Anoscopy Guided Biopsy?

Speaker(s) : S. Araujo , S. Araujo I. Cecconello , S. Araujo I. Cecconello R. Genevcius , S. Araujo I. Cecconello R. Genevcius E. Gutierrez , S. Araujo I. Cecconello R. Genevcius E. Gutierrez D. Kiss , S. Araujo I. Cecconello R. Genevcius E. Gutierrez D. Kiss C. Marques , S. Araujo I. Cecconello R. Genevcius E. Gutierrez D. Kiss C. Marques C. Nahas , S. Araujo I. Cecconello R. Genevcius E. Gutierrez D. Kiss C. Marques C. Nahas S. Nahas , S. Araujo I. Cecconello R. Genevcius E. Gutierrez D. Kiss C. Marques C. Nahas S. Nahas M. Nakai , S. Araujo I. Cecconello R. Genevcius E. Gutierrez D. Kiss C. Marques C. Nahas S. Nahas M. Nakai E. Silva Filho


______________________

HIV and Anal Canal Cancer Outcomes: A Single Institution's Experience

Speaker(s) : A. Halverson , A. Halverson M. Hogg , A. Halverson M. Hogg D. Popowich


______________________

Gene Expression in Sessile Serrated Adenoma

Speaker(s) : M. Caruso , M. Caruso G. Goodall , M. Caruso G. Goodall J. Moore , M. Caruso G. Goodall J. Moore A. Ruszkiewicz , M. Caruso G. Goodall J. Moore A. Ruszkiewicz M. Thomas


______________________

Lymphovascular Invasion in Colorectal Cancer is Associated with Alterations in Cell Adhesion and Cytoskeletal Pathways

Speaker(s) : M. Alvarado , M. Alvarado S. Eschrich , M. Alvarado S. Eschrich E. Jensen , M. Alvarado S. Eschrich E. Jensen J. Lewis , M. Alvarado S. Eschrich E. Jensen J. Lewis Q. Ly , M. Alvarado S. Eschrich E. Jensen J. Lewis Q. Ly J. McLoughlin , M. Alvarado S. Eschrich E. Jensen J. Lewis Q. Ly J. McLoughlin R. Nair , M. Alvarado S. Eschrich E. Jensen J. Lewis Q. Ly J. McLoughlin R. Nair D. Shibata , M. Alvarado S. Eschrich E. Jensen J. Lewis Q. Ly J. McLoughlin R. Nair D. Shibata E. Siegel , M. Alvarado S. Eschrich E. Jensen J. Lewis Q. Ly J. McLoughlin R. Nair D. Shibata E. Siegel T. Yeatman


______________________

Copy Number and Methylation Analysis of Microsatellite and Chromosome Stable Colorectal Cancers Associated with Poor Outcome

Speaker(s) : A. Banerjea , A. Banerjea S. Dorudi , A. Banerjea S. Dorudi L. Hammond , A. Banerjea S. Dorudi L. Hammond N. Sengupta , A. Banerjea S. Dorudi L. Hammond N. Sengupta A. Silver , A. Banerjea S. Dorudi L. Hammond N. Sengupta A. Silver N. Suraweera


______________________

If Colon and Rectal Cancers Wear Different Genes, Why are they Thrown Together in the Wash?

Speaker(s) : G. Casey , G. Casey J. Church , G. Casey J. Church K. DeJulius , G. Casey J. Church K. DeJulius M. Kalady , G. Casey J. Church K. DeJulius M. Kalady E. Manilich , G. Casey J. Church K. DeJulius M. Kalady E. Manilich J. Sanchez


______________________

Patients with Low Rectal Cancer Treated by Abdomino-Perineal Excision Worse Tumors and Higher Involved Margin Rates Compared with Those Treated by Anterior Resection

Speaker(s) : G. Brown , G. Brown I. Daniels , G. Brown I. Daniels R. Heald , G. Brown I. Daniels R. Heald B. Moran , G. Brown I. Daniels R. Heald B. Moran P. Qurike , G. Brown I. Daniels R. Heald B. Moran P. Qurike O. Shihab


______________________

Influence of Aspirin and NSAIDs on Colorectal Cancer Risk and Survival

Speaker(s) : R. Barnetson , R. Barnetson H. Campbell , R. Barnetson H. Campbell R. Cetnarskyj , R. Barnetson H. Campbell R. Cetnarskyj F. Din , R. Barnetson H. Campbell R. Cetnarskyj F. Din M. Dunlop , R. Barnetson H. Campbell R. Cetnarskyj F. Din M. Dunlop S. Farrington , R. Barnetson H. Campbell R. Cetnarskyj F. Din M. Dunlop S. Farrington M. Porteous , R. Barnetson H. Campbell R. Cetnarskyj F. Din M. Dunlop S. Farrington M. Porteous L. Stark , R. Barnetson H. Campbell R. Cetnarskyj F. Din M. Dunlop S. Farrington M. Porteous L. Stark A. Tenesa , R. Barnetson H. Campbell R. Cetnarskyj F. Din M. Dunlop S. Farrington M. Porteous L. Stark A. Tenesa E. Theodoratou


______________________

The Role of 18- FDG PETCT in the Clinical Management of Anal Squamous Cell Carcinoma

Speaker(s) : G. Blackman , G. Blackman P. Boulos , G. Blackman P. Boulos P. Ell , G. Blackman P. Boulos P. Ell A. Engledow , G. Blackman P. Boulos P. Ell A. Engledow A. Groves , G. Blackman P. Boulos P. Ell A. Engledow A. Groves J. Peck


______________________

Is Surveillance for Recurrent Anal Cancer Beneficial after Complete Tumor Regression?

Speaker(s) : B. Davis , B. Davis D. O'Brien , B. Davis D. O'Brien J. Rafferty

Neoplasia III

Objectives : At the conclusion of this session, participants should be able to: (49) understand the impact of anastomotic leak and intra-abdominal abscess on colorectal cancer recurrence and long-term survival; (50) understand that pseudomyxoma peritonei usually originates from a perforated tumour of the appendix; (51) a) appreciate that an association exists between duodenal polyposis and pouch polyposis, a finding that has not been demonstrated previously and b) focus future research on aetiological factors beyond a defective APC gene that are associated with the development of duodenal and pouch polyposis; (52) a) understand the incidence of colorectal metastases to the lungs without liver involvement is not as rare as initially thought and b) manage and ensure that the follow up surveillance of colorectal cancer patients is not compromised; (53) feasiblity and possible advantages of 'the liver first' approach in patients with locally advanced rectal cancer with synchronous liver metastases; (54) explain how the results show that a simple follow up policy can provide as high a detection rate of asymptomatic recurrence when a secondary curative resection prolongs survival compared to more intensive follow up policies; (55) understand that local recurrence of rectal cancer is still a problem in local excision, nonrestorative resections and tumours within 6cm of the anal verge. Optimal staging, neoadjuvant therapy and surgery might improve outcomes in this high risk group; (56) a) assess current epidemiologic trends of colorectal neoplasia in the United States with respect to age, year, and type of resection and b) consider offering screening colonoscopy to patients before age 50; (57) understand the limitations of endoscopic biopsy for the diagnosis of colorectal cancer and appreciate the role of brush cytology to improve the accuracy of endoscopic biopsy; (58) appreciate that DNA quantification of rectally harvested coloncytes may hold promise as a new screening tool for colorectal cancer; (59) understand the reliability and use of Minimal Preparation CT colonography for the detection of colonic carcinoma; (60) examine the role of screening wih facal occult blood as a tool.

______________________

Anastomotic Leak and Intra-abdominal Abscess after Resection for Colorectal Cancer: Do These Complications Really Influence Long-term Survival and Recurrence?

Speaker(s) : J. Eberhardt , J. Eberhardt R. Kiran , J. Eberhardt R. Kiran I. Lavery


______________________

Five-year Overall and Disease-free Survival in 170 Patients with Pseudomyxoma Peritonei from a Perforated Appendiceal Tumor following Complete Tumor Removal and Intraperitoneal Chemotherapy

Speaker(s) : T. Cecil , T. Cecil A. Mirnezami , T. Cecil A. Mirnezami B. Moran , T. Cecil A. Mirnezami B. Moran R. Sexton , T. Cecil A. Mirnezami B. Moran R. Sexton H. Yano


______________________

Development of Pouch Polyposis after Ileal Pouch Anal Anstomosis for Familial Adenomatous Polyposis is Associated with Severity of Duodenal Polyposis

Speaker(s) : S. Clark , S. Clark R. Man , S. Clark R. Man K. Neale , S. Clark R. Man K. Neale P. Tekkis , S. Clark R. Man K. Neale P. Tekkis A. von Roon , S. Clark R. Man K. Neale P. Tekkis A. von Roon O. Will


______________________

How Uncommon are Isolated Lung Metastases in Colorectal Cancer? A Review of 754 Patients over 4 1/2 Years

Speaker(s) : G. Lopes , G. Lopes R. Sim , G. Lopes R. Sim K. Tan


______________________

The "Liver First Approach" for Patients with Locally Advanced Rectal Cancer with Synchronous Liver Metastases

Speaker(s) : J. de Wilt , J. de Wilt A. Eggermont , J. de Wilt A. Eggermont J. Nuytens , J. de Wilt A. Eggermont J. Nuytens A. Planting , J. de Wilt A. Eggermont J. Nuytens A. Planting A. van der Pool , J. de Wilt A. Eggermont J. Nuytens A. Planting A. van der Pool C. Verhoef


______________________

The Value of CEA and CT in Early Diagnosis of Colorectal Cancer Recurrence

Speaker(s) : P. Boulos , P. Boulos D. Gore , P. Boulos D. Gore D. Raptis


______________________

Local Recurrence following Rectal Cancer Surgery in a Specialist Unit: Incidence, Site and Outcome in a Consecutive Series of 459 Cases

Speaker(s) : T. Cecil , T. Cecil A. Mirnezami , T. Cecil A. Mirnezami B. Moran , T. Cecil A. Mirnezami B. Moran A. Myers , T. Cecil A. Mirnezami B. Moran A. Myers R. Sexton


______________________

An Argument for Screening Colonoscopy before Age 50: Current Epidemiologic Trends in the United States

Speaker(s) : K. Alavi , K. Alavi E. Cooley , K. Alavi E. Cooley J. Maykel , K. Alavi E. Cooley J. Maykel J. McPhee , K. Alavi E. Cooley J. Maykel J. McPhee J. Simons , K. Alavi E. Cooley J. Maykel J. McPhee J. Simons W. Sweeney , K. Alavi E. Cooley J. Maykel J. McPhee J. Simons W. Sweeney J. Tseng


______________________

Endoscopic Brush Cytology for the Diagnosis of Colorectal Cancer

Speaker(s) : R. Brouwer , R. Brouwer J. Gunn , R. Brouwer J. Gunn J. Hartley , R. Brouwer J. Gunn J. Hartley A. MacDonald , R. Brouwer J. Gunn J. Hartley A. MacDonald R. Matthews , R. Brouwer J. Gunn J. Hartley A. MacDonald R. Matthews J. Monson


______________________

Detection of Colorectal Cancer by DNA Quantification of Exfoliated Colonocytes

Speaker(s) : A. Bajwa , A. Bajwa P. Boulos , A. Bajwa P. Boulos R. Navaratnam , A. Bajwa P. Boulos R. Navaratnam A. Obichere , A. Bajwa P. Boulos R. Navaratnam A. Obichere O. Ogunbiyi , A. Bajwa P. Boulos R. Navaratnam A. Obichere O. Ogunbiyi D. Raptis


______________________

Minimal Preparation CT Colonography: A Reliable Test for Detection of Colonic Carcinoma in Elderly Patients

Speaker(s) : H. Adams , H. Adams S. Akhtar , H. Adams S. Akhtar M. Davies , H. Adams S. Akhtar M. Davies G. Williams


______________________

Impact of the National Bowel Cancer Screening Program Utilizing Fecal Occult Blood Test Screening on the Diagnosis of Colorectal Cancer

Speaker(s) : F. Chen , F. Chen P. Gibbs , F. Chen P. Gibbs I. Hastie , F. Chen P. Gibbs I. Hastie I. Hayes , F. Chen P. Gibbs I. Hastie I. Hayes A. Hunter , F. Chen P. Gibbs I. Hastie I. Hayes A. Hunter I. Jones , F. Chen P. Gibbs I. Hastie I. Hayes A. Hunter I. Jones S. McLaughlin , F. Chen P. Gibbs I. Hastie I. Hayes A. Hunter I. Jones S. McLaughlin N. Reiger , F. Chen P. Gibbs I. Hastie I. Hayes A. Hunter I. Jones S. McLaughlin N. Reiger S. Shedda , F. Chen P. Gibbs I. Hastie I. Hayes A. Hunter I. Jones S. McLaughlin N. Reiger S. Shedda I. Skinner , F. Chen P. Gibbs I. Hastie I. Hayes A. Hunter I. Jones S. McLaughlin N. Reiger S. Shedda I. Skinner M. Steele

Norman Nigro Research Lectureship

Objectives :

______________________

Antiangiogenesis as Part of a Combined Modality Approach for the Treatment of Cancer

Speaker(s) : Michael S. O’Reilly, MD

Outcomes

Objectives : At the conclusion of this session, participants should be able to: (73) understand the importance of a centralized service to improve the standard of care in the management of these rare tumors; (74) understand the impact of different aspects of organizational infrastructure on patient outcomes following bowel cancer surgery; (75) a) understand the Delphi approach to development of consensus and b) informed of the research questions of greatest importance to ASCRS members; (76) understand how population demographic shifts impacts the demand for colorectal surgical services; (77) a) stratify colorectal patients with respect to risk of development of post-operative surgical site infection and b) interpret national quality outcomes data as it pertains to colorectal surgery; (78) comprehend the importance of Clostridium difficile in regards to the in-patient population and its subsequent impact upon the colorectal service; (79) a) understand the common causes of death after Colectomy and b) define the relationship of surgeon error to death after Colectomy; (80) a) assess the predicted mortality of patients with liver disease undergoing colorectal surgery and b) develop an operative plan for the patient with cirrhosis undergoing colorectal surgery; (81) analyze the similarities and differences between colorectal surgery fellowship programs in Australia, the United Kingdom, and North America; (82) a) laparoscopic colorectal resections can be learnt safely and b) understand the learning curve continues beyond 200 cases; (83) a) understand the major mortality and hospital stay benefits of laparoscopic colorectal surgery and b) comprehend the volume of laparoscopic colorectal surgery undertaken by British surgeons over the last decade; and (84) a) appreciate the power of a standardized, centralized quality data collection processes; b) become familiar with the important lessons elucidated through from a non-VA collaboration and c) recognizes the stengths and weaknesses specific to the clinical relavance of large database analysis.

______________________

The Treatment and Outcomes of Peritoneal Tumors through a Centralized National Service

Speaker(s) : M. Davies ,